Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial

Astrid E Persson; Elisabeth Kjellén; Hans Garmo; Gabriel Adrian; Pär Stattin; Anders Widmark; Per Nilsson; Adalsteinn Gunnlaugsson

doi:10.1016/S0167-8140(24)03483-2

Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial

Astrid E Persson, Elisabeth Kjellén, Hans Garmo, Gabriel Adrian, Pär Stattin, Anders Widmark, Per Nilsson, Adalsteinn Gunnlaugsson

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	S2287-S2291
Number of pages	4
DOIs	https://doi.org/10.1016/S0167-8140(24)03483-2
Publication status	Published - 2024 May 3
Event	ESTRO 2024: Radiation Oncology: Bridging the Care Gap - Scottish Event Campus, Glasgow, United Kingdom Duration: 2024 May 3 → 2024 May 7 https://www.estro.org/Congresses/ESTRO-2024

Conference

Conference	ESTRO 2024
Country/Territory	United Kingdom
City	Glasgow
Period	2024/05/03 → 2024/05/07
Internet address	https://www.estro.org/Congresses/ESTRO-2024

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0167-8140(24)03483-2Licence: Unspecified

https://user-swndwmf.cld.bz/ESTRO-2024-Abstract-Book/2295/Licence: Unspecified

1 Web publication/Blog post

Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report
Persson, A. E., 2024 Jul 10, European Society for Radiotherapy and Oncology (ESTRO).
Research output: Other contribution › Web publication/Blog post › Research

Open Access

1 Participation in conference

ESTRO 2024
Astrid Persson (Presenter)
2024 May 3 → 2024 May 7
Activity: Participating in or organising an event › Participation in conference

Young Researcher Award
Persson, Astrid (Recipient), 2024 May 6
Prize: Prize (including medals and awards)

Cite this

@conference{8ed0bdce9fe34fc4a828dba77092dc66,

title = "Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial",

author = "Persson, {Astrid E} and Elisabeth Kjell{\'e}n and Hans Garmo and Gabriel Adrian and P{\"a}r Stattin and Anders Widmark and Per Nilsson and Adalsteinn Gunnlaugsson",

year = "2024",

month = may,

day = "3",

doi = "10.1016/S0167-8140(24)03483-2",

language = "English",

pages = "S2287--S2291",

note = "ESTRO 2024 : Radiation Oncology: Bridging the Care Gap ; Conference date: 03-05-2024 Through 07-05-2024",

url = "https://www.estro.org/Congresses/ESTRO-2024",

}

TY - CONF

T1 - Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial

AU - Persson, Astrid E

AU - Kjellén, Elisabeth

AU - Garmo, Hans

AU - Adrian, Gabriel

AU - Stattin, Pär

AU - Widmark, Anders

AU - Nilsson, Per

AU - Gunnlaugsson, Adalsteinn

PY - 2024/5/3

Y1 - 2024/5/3

U2 - 10.1016/S0167-8140(24)03483-2

DO - 10.1016/S0167-8140(24)03483-2

M3 - Abstract

SP - S2287-S2291

T2 - ESTRO 2024

Y2 - 3 May 2024 through 7 May 2024

ER -

Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial

Conference

Subject classification (UKÄ)

UN SDGs

Access to Document

Research output

Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report

Activities

ESTRO 2024

Prizes

Young Researcher Award

Cite this